Icon Genetics GmbH:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Icon Genetics GmbH - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C12327
◆発行会社(調査会社):GlobalData
◆発行日:2018年12月
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ドイツ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Icon Genetics GmbH (Icon Genetics), a subsidiary of Denka Co Ltd, is a technology company that offers plant engineering technologies. The company develops, manufactures and markets biopharmaceutical product candidates, engineered organisms and technology platforms for plant biotechnology and plant-based production. It commercializes proprietary transgene operating systems suites of technologies for nuclear transformation of plants, plastid transformation and pro-viral transfection of plants. The company offers production platforms and product prototypes for various pharmaceutical, animal health and chemical biotech markets. Icon Genetics is headquartered in Halle, Germany.

Icon Genetics GmbH – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Icon Genetics GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Icon Genetics GmbH, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Icon Genetics GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Icon Genetics GmbH, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Icon Genetics GmbH, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Icon Genetics GmbH, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Council for Scientific and Industrial Research Enters Into Partnership with Icon Genetics 10
Merger 11
Kentucky Bioprocessing, Icon Genetics And Mapp Biopharma Plan To Merge 11
Acquisition 12
Denki Kagaku Acquires Icon Genetics from Nomad Bioscience for USD81.6 Million 12
Nomad Bioscience Acquires Icon Genetics From Bayer Innovation 13
Icon Genetics GmbH – Key Competitors 14
Icon Genetics GmbH – Key Employees 15
Icon Genetics GmbH – Locations And Subsidiaries 16
Head Office 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables
Icon Genetics GmbH, Pharmaceuticals & Healthcare, Key Facts 2
Icon Genetics GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Icon Genetics GmbH, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Icon Genetics GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Icon Genetics GmbH, Deals By Therapy Area, 2012 to YTD 2018 8
Icon Genetics GmbH, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Council for Scientific and Industrial Research Enters Into Partnership with Icon Genetics 10
Kentucky Bioprocessing, Icon Genetics And Mapp Biopharma Plan To Merge 11
Denki Kagaku Acquires Icon Genetics from Nomad Bioscience for USD81.6 Million 12
Nomad Bioscience Acquires Icon Genetics From Bayer Innovation 13
Icon Genetics GmbH, Key Competitors 14
Icon Genetics GmbH, Key Employees 15

List of Figures
Icon Genetics GmbH, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Icon Genetics GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Icon Genetics GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Icon Genetics GmbH, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Icon Genetics GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Icon Genetics GmbH, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Icon Genetics GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Icon Genetics GmbH, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Icon Genetics GmbH:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • American Builders & Contractors Supply Co Inc:企業の戦略・SWOT・財務情報
    American Builders & Contractors Supply Co Inc - Strategy, SWOT and Corporate Finance Report Summary American Builders & Contractors Supply Co Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, opera …
  • Verily Life Sciences LLC-医療機器分野:企業M&A・提携分析
    Summary Verily Life Sciences LLC (Verily), formerly known as Google Life Sciences LLC, a subsidiary of Alphabet Inc is a life sciences research and engineering organization which develops tools for prevention, detection, and management of diseases. The company develops tools for various projects, su …
  • Integra LifeSciences Holdings Corp (IART):企業の財務・戦略的SWOT分析
    Integra LifeSciences Holdings Corp (IART) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strength …
  • Intracom Holdings S.A. (INTRK):企業の財務・戦略的SWOT分析
    Intracom Holdings S.A. (INTRK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Transport for London:企業の戦略的SWOT分析
    Transport for London - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • MISC Bhd (MISC):企業の財務・戦略的SWOT分析
    MISC Bhd (MISC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • ResApp Health Ltd (RAP):企業の製品パイプライン分析
    Summary ResApp Health Ltd (ResApp) formerly, Narhex Life Sciences Limited is a digital health company that develops smartphone applications for the diagnosis and management of respiratory disease. It's digital healthcare solutions assist doctors and patients to diagnose and manage respiratory diseas …
  • Silver Fern Farms Limited:企業の戦略的SWOT分析
    Silver Fern Farms Limited - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Cellectis SA (ALCLS):企業の財務・戦略的SWOT分析
    Summary Cellectis SA (Cellectis) is a clinical-stage biopharmaceutical company that research, develop and commercialise rational genome engineering technologies. The company pioneers gene editing company, deploying core proprietary technologies to develop off-the-shelf immunotherapies to target and …
  • Streamline Health Solutions Inc (STRM):医療機器:M&Aディール及び事業提携情報
    Summary Streamline Health Solutions Inc (Streamline Health) is a medical technology company that offers patient engagement and SaaS-based solutions. The company provides solutions including HIM, patient engagement, patient care, coding and CDI, and financial management solutions. It offers its patie …
  • Seacor Holdings Inc (CKH):石油・ガス:M&Aディール及び事業提携情報
    Summary Seacor Holdings Inc (Seacor) is a diversified holding company that offers domestic and international transportation and logistics and risk management consultancy services. The company operates through business segments such as ocean transportation and logistics services, inland transportatio …
  • Tapestry, Inc.:企業の戦略・SWOT・財務情報
    Tapestry, Inc. - Strategy, SWOT and Corporate Finance Report Summary Tapestry, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • New World Development Company Limited:企業の戦略・SWOT・財務分析
    New World Development Company Limited - Strategy, SWOT and Corporate Finance Report Summary New World Development Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analy …
  • GTT Communications Inc (GTT):企業の財務・戦略的SWOT分析
    GTT Communications Inc (GTT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Fabasoft Ag
    Fabasoft Ag - Strategy, SWOT and Corporate Finance Report Summary Fabasoft Ag - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • VA Tech Wabag Ltd (WABAG):企業の財務・戦略的SWOT分析
    Summary VA Tech Wabag Ltd (VA Tech) is engaged in the planning, design, installation and operation of water and wastewater plants. The company’s services include water treatment, desalination, waste water treatment, water reclamation, and sludge treatment. Its projects comprise Sundarijal Water Trea …
  • Vitro, S.A.B. de C.V.:企業の戦略・SWOT・財務情報
    Vitro, S.A.B. de C.V. - Strategy, SWOT and Corporate Finance Report Summary Vitro, S.A.B. de C.V. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • University of Connecticut:製薬・医療:M&Aディール及び事業提携情報
    Summary University of Connecticut (UCONN) is an educational service provider that offers graduation programs and other courses. The university offers undergraduate degree courses, graduate degree courses, professional degree programs, and research programs. It offers educational and training program …
  • Diehl Stiftung & Co. KG:企業の戦略・SWOT・財務分析
    Diehl Stiftung & Co. KG - Strategy, SWOT and Corporate Finance Report Summary Diehl Stiftung & Co. KG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Darden Restaurants, Inc.:戦略・SWOT・企業財務分析
    Darden Restaurants, Inc. - Strategy, SWOT and Corporate Finance Report Summary Darden Restaurants, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆